Skip to main content

Vaxcyte, Inc 10-Q for FY2026 Q1

Vaxcyte, Inc. (PCVX)

10-Q 2026-05-06 For: 2026-03-31
View Original
Added on May 06, 2026

About this 10-Q

Vaxcyte, Inc filed this 10-Q on May 6, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$320.62M
compared with a net loss of $140.72M a year earlier
Diluted EPS
-$2.30
compared with -$1.04 a year earlier